Syndax Pharmaceuticals (SNDX) Current Deferred Revenue (2015 - 2021)
Syndax Pharmaceuticals (SNDX) reported Current Deferred Revenue of $1.52 million for Q2 2021, unchanged from $1.52 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Current Deferred Revenue (2015 - 2021) Analysis & Trends
Dating back to Q4 2015, Syndax Pharmaceuticals' Current Deferred Revenue record includes 23 quarters.
- Current Deferred Revenue has a five-year compound annual growth rate of 4.5% (FY2015 to FY2020).
- By year, Current Deferred Revenue came in at $1.52 million in FY2019 (unchanged), $1.52 million in FY2018 (-3.6%), $1.57 million in FY2017 (+28.9%) and $1.22 million in FY2016 (unchanged).
- Five-year quarterly Current Deferred Revenue spans a low of $1.22 million in Q3 2016 and a high of $1.57 million in Q4 2017.
- The high point for year-over-year Current Deferred Revenue in five years was Q4 2017 (growth of 28.9%); the low point was Q4 2018 (a decline of 3.6%).
- Per Business Quant data, the three quarters before Q2 2021 came in at $1.52 million (Q1 2021), $1.52 million (Q4 2020) and $1.52 million (Q3 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Syndax Pharmaceuticals | 1.17 Bn | -558.85 Mn | 69.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 1.52 Mn |
| Mar 31, 2021 | 1.52 Mn |
| Dec 31, 2020 | 1.52 Mn |
| Sep 30, 2020 | 1.52 Mn |
| Jun 30, 2020 | 1.52 Mn |
| Mar 31, 2020 | 1.52 Mn |
| Dec 31, 2019 | 1.52 Mn |
| Sep 30, 2019 | 1.52 Mn |
| Jun 30, 2019 | 1.52 Mn |
| Mar 31, 2019 | 1.52 Mn |
| Dec 31, 2018 | 1.52 Mn |
| Sep 30, 2018 | 1.52 Mn |
| Jun 30, 2018 | 1.52 Mn |
| Mar 31, 2018 | 1.52 Mn |
| Dec 31, 2017 | 1.57 Mn |
| Sep 30, 2017 | 1.22 Mn |
| Jun 30, 2017 | 1.22 Mn |
| Mar 31, 2017 | 1.22 Mn |
| Dec 31, 2016 | 1.22 Mn |
| Sep 30, 2016 | 1.22 Mn |
API Access
Syndax Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();